11-64808030-T-A
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001370259.2(MEN1):c.515A>T(p.Asp172Val) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D172Y) has been classified as Pathogenic.
Frequency
Consequence
NM_001370259.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEN1 | NM_001370259.2 | c.515A>T | p.Asp172Val | missense_variant | 3/10 | ENST00000450708.7 | NP_001357188.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEN1 | ENST00000450708.7 | c.515A>T | p.Asp172Val | missense_variant | 3/10 | 5 | NM_001370259.2 | ENSP00000394933 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461860Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727234
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2016 | The D172V mutation has not been published as a germline mutation, nor has it been reported as a benign polymorphism to our knowledge. It has been published as a somatic mutation in a neuroendocrine lung tumor (Gortz et al., 1999). Another germline mutation as this same position (D172Y) has also been published in association with MEN1 (Giraud et al., 1998). D172V is a non-conservative amino acid substitution as a negatively-charged Aspartic Acid is replaced with a neutral Valine residue at a position that is highly conserved across species. Furthermore, the NHLBI ESP Exome Variant Server reports D172V was not observed in approximately 6,000 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 14, 2017 | The p.D172V variant (also known as c.515A>T), located in coding exon 2 of the MEN1 gene, results from an A to T substitution at nucleotide position 515. The aspartic acid at codon 172 is replaced by valine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant has been detected in multiple individuals whose personal and familial clinical histories are consistent with MEN1 (Ambry internal data). In addition, this alteration is expected to have the same destabilization energy as MEN1 p.D172Y, another substitution at the same amino acid position (Ambry internal data). p.D172Y has been identified in multiple patients diagnosed with sporadic or familial MEN1 (Giraud, S et al. Am J Hum Genet. 1998 Aug;63(2):455-67; Poncin, J et al. Hum Mutat. 1999;13(1):54-60; Verges, B et al. J Clin Endocrinol Metab. 2002 Feb;87(2):457-65; Wautot, V et al. Hum Mutat. 2002 Jul;20(1):35-47; Fujii, T et al. Pathol Int. 1999 Nov;49(11):968-73). Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at